FDA News

FDA clears IND application for natural killer cell-based COVID-19 therapy

April 2, 2020
The FDA cleared an investigational new drug application for CYNK-001 for the treatment of adults with COVID-19 infection, according to the…
Breaking News

FDA loosens constraints on blood donations from MSM, other groups because of COVID-19

April 2, 2020
The FDA has revised its deferral policy for blood donations by men who have sex with men and their partners, as well as individuals with tattoos and…
In the Journals

Breastfeeding may reduce risk for ovarian cancer

April 2, 2020
Breastfeeding appeared to be associated with reduced risk for overall ovarian cancer and for the high-grade serous subtype, according to results of a…
Feature

Guidelines aim to ensure proper care of patients with sickle cell disease amid COVID-19 pandemic

April 2, 2020
Acute and chronic complications of sickle cell disease necessitate frequent interaction with the medical system. These complications — which…
FDA News

FDA grants fast track designation to IPI-549 for urothelial cancer

April 2, 2020
The FDA granted fast track designation to IPI-549 in combination with nivolumab for the treatment of advanced urothelial cancer. IPI-549 (Infinity…
In the Journals

Smoking not linked to COVID-19 severity

April 2, 2020
Researchers found no link between cigarette smoking and the severity of COVID-19 among cases in China, according to results of a preliminary…
FDA News

FDA approves Sevenfact for certain adults, adolescents with hemophilia

April 1, 2020
The FDA approved coagulation factor VIIa (recombinant)-jncw for the treatment and control of bleeding episodes among certain adults and adolescents…
Feature

Convalescent plasma transfusion shows promise for severely ill patients with COVID-19

April 1, 2020
Preliminary research has shown the potential of convalescent plasma therapy to improve clinical outcomes of patients with severe disease related to…

Data registry to guide care for patients with COVID-19, blood cancers

April 1, 2020
ASH Research Collaborative’s Data Hub launched an international data registry to help inform care for individuals with blood cancers and…
FDA News

FDA grants fast track designation to ME-401 for advanced follicular lymphoma

April 1, 2020
The FDA granted fast track designation to ME-401 for the treatment of adults with relapsed or refractory follicular lymphoma, according to the…
FDA News

FDA grants priority review to Ryoncil for certain children with acute GVHD

April 1, 2020
The FDA granted priority review to the allogeneic cell therapy remestemcel-L for the treatment of children with steroid-refractory acute…

Q&A: COVID-19 disrupts 2020 census

April 1, 2020
The negative downstream effects of the COVID-19 pandemic may extend to the United States census, a business and economy expert told Healio Primary…
FDA News

Bristol-Myers Squibb, bluebird bio submit biologics license application for advanced multiple myeloma CAR-T

March 31, 2020
Bristol-Myers Squibb and its subsidiary, bluebird bio, have submitted a biologics license application to the FDA for idecabtagene vicleucel —…
FDA News

FDA grants SEL120 orphan drug designation for acute myeloid leukemia

March 31, 2020
The FDA granted orphan drug designation to SEL120 for the treatment of acute myeloid leukemia, according to the agent’s manufacturer. SEL120…
In the Journals

Melanoma incidence in men, women differs by age, anatomic site

March 31, 2020
Melanoma incidence rates differ between men and women by age and anatomic site in predominantly fair-skinned populations, according to a…
In the Journals

Certain medical devices with FDA priority review have higher recall rates

March 31, 2020
High-risk, or class 3, medical devices that underwent FDA priority review had higher recall rates and less time on the market before serious recalls…

10 important updates in multiple myeloma

March 31, 2020
March is Myeloma Awareness Month. The observance is intended to increase awareness about the prevalence of multiple myeloma, its symptoms and the…
In the Journals

Blood test detects dozens of cancer types, often before symptoms emerge

March 31, 2020
A novel blood test accurately detected more than 50 types of cancer with a specificity of 99.3%, according to results of the prospective Circulating…
Trend Watch

Researchers to collaborate on natural killer cell-based COVID-19 treatment

March 30, 2020
Green Cross LabCell, a South Korea-based biopharmaceutical company, announced it will begin development of a COVID-19 treatment based on its…
FDA News

FDA approves Imfinzi for extensive-stage small cell lung cancer

March 30, 2020
The FDA approved durvalumab in combination with standard chemotherapy as first-line treatment of adults with extensive-stage small cell lung cancer…